Indonesia vs Philippines: Share of the population living with HIV receiving antiretroviral therapy
Indonesia
40.7%
in 2024
Philippines
40.4%
in 2024
Indonesia rank
138th
Philippines rank
140th
Share of the population living with HIV receiving antiretroviral therapy over time
- Indonesia
- Philippines
How they compare
Indonesia currently reports 40.7% against 40.4% in Philippines, a difference of 0.3%.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Philippines ahead.
Indonesia ranks 138th and Philippines ranks 140th of 149 countries.
Across the 4 decades both report, Indonesia averaged higher in 1 and Philippines in 3.
Head to head by decade
| Decade | Indonesia | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | Indonesia |
| 2000s | 1.2% | 1.4% | 0.2% | Philippines |
| 2010s | 11.9% | 20.8% | 9.0% | Philippines |
| 2020s | 30.5% | 39.8% | 9.3% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Indonesia or Philippines?
- Indonesia, at 40.7% against 40.4% in Philippines as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Indonesia and Philippines?
- 0.3%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Philippines?
- 35 years are reported by both, from 1990 to 2024.
- How do Indonesia and Philippines rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Indonesia ranks 138th and Philippines ranks 140th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.